Skip to main content

Thermo Fisher Scientific balance sheet

  • TMO · NYSE
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$700.22+0.11%Close 13 Nov 2026

At the end of fiscal 2025 (the year to 31 Dec 2025), Thermo Fisher Scientific reported total assets of $110.3B, $9.85B in cash and equivalents, $40.85B of total debt; shareholders' equity was $53.41B.

From Thermo Fisher Scientific's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

Thermo Fisher Scientific balance sheet, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$625.1M$1.28B$1.56B$917.1M$1.02B$805.6M$5.83B$1.34B$452.1M$786.0M$1.33B$2.10B$2.40B$10.32B$4.48B$8.52B$8.08B$4.01B$9.85B
Short-term investments—$7.50M$7.10M$8.90M$4.30M$4.30M$4.50M$8.50M————————$3.00M$1.56B$253.0M
Cash and short-term investments$625.1M$1.29B$1.57B$926.0M$1.02B$809.9M$5.83B$1.35B$452.1M$786.0M$1.33B$2.10B$2.40B$10.32B$4.48B$8.52B$8.08B$5.57B$10.11B
Accounts receivable—$1.48B$1.41B$1.47B$1.76B$1.80B$1.94B$2.47B$2.54B$3.05B$3.88B$4.14B$4.35B$5.74B$7.98B$8.12B$8.22B$8.19B$8.90B
Inventory—$1.17B$1.13B$1.17B$1.33B$1.44B$1.49B$1.86B$1.99B$2.21B$2.97B$3.00B$3.37B$4.03B$5.05B$5.63B$5.09B$4.98B$5.42B
Current assets—$4.35B$4.53B$4.13B$4.82B$4.83B$9.88B$6.54B$5.74B$7.02B$9.42B$10.63B$11.89B$21.96B$20.11B$25.23B$24.59B$22.14B$28.71B
Property, plant and equipment—$1.28B$1.33B$1.36B$1.61B$1.73B$1.77B$2.43B$2.45B$2.58B$4.05B$4.17B$4.75B$5.91B$8.33B$9.28B$9.45B$9.31B$10.56B
Goodwill—$8.68B$8.98B$9.00B$11.97B$12.47B$12.50B$18.84B$18.83B$21.33B$25.29B$25.35B$25.71B$26.04B$41.92B$41.20B$44.02B$45.85B$49.36B
Acquired intangibles—$6.42B$6.34B$5.91B$7.82B$7.80B$7.07B$14.11B$12.76B$13.97B$16.68B$14.98B$14.01B$12.69B$20.11B$17.44B$16.67B$15.53B$15.84B
Total assets—$21.09B$21.63B$21.35B$26.83B$27.44B$31.86B$42.85B$40.83B$45.91B$56.67B$56.23B$58.38B$69.05B$95.12B$97.15B$98.73B$97.32B$110.3B
Accounts payable—$539.5M$533.6M$546.7M$612.3M$641.4M$691.5M$820.7M$822.2M$926.0M$1.43B$1.61B$1.92B$2.17B$2.87B$3.38B$2.87B$3.08B$3.62B
Unearned revenue, current—$135.3M$139.8M$158.2M$192.5M$196.5M$198.9M$311.9M$317.9M$486.0M$0.00$809.0M$916.0M$1.27B$2.65B$2.60B$2.69B$2.85B$2.71B
Short-term borrowings——————$280.0M$0.00$50.00M$953.0M$960.0M$693.0M———————
Long-term debt · current portion—$14.80M$117.5M$105.8M$1.27B$93.10M$987.7M$2.21B$1.05B$1.25B$2.13B$1.27B$676.0M$2.63B$2.54B$5.58B$3.61B$2.21B$3.53B
Current liabilities—$1.54B$1.64B$1.71B$3.11B$2.09B$3.13B$5.35B$4.15B$4.87B$7.05B$6.15B$6.20B$10.30B$13.44B$17.01B$14.01B$13.33B$15.19B
Long-term debt · non-current—$2.00B$2.06B$2.03B$5.76B$7.03B$9.50B$12.35B$11.42B$15.37B$18.87B$17.72B$17.08B$19.11B$32.33B$28.91B$31.31B$29.06B$35.85B
Operating lease liability————————————$738.0M$810.0M$1.47B$1.58B$1.51B$1.50B$1.47B
Finance lease liability—————————————$7.00M$200.0M$210.0M$190.0M$202.0M$213.0M
Total liabilities—$6.16B$6.19B$5.99B$11.80B$11.98B$15.01B$22.30B$19.48B$24.37B$31.26B$28.65B$28.71B$34.53B$54.15B$53.01B$51.88B$47.65B$56.81B
Retained earnings—$3.50B$4.35B$5.39B$6.72B$7.70B$8.75B$10.41B$12.14B$13.93B$15.91B$18.70B$22.09B$28.12B$35.43B$41.91B$47.36B$53.10B$59.16B
Minority interest—————————————$10.00M$62.00M$54.00M−$11.00M−$33.00M$7.00M
Shareholders' equity$14.46B$14.93B$15.43B$15.36B$15.04B$15.46B$16.86B$20.55B$21.35B$21.54B$25.41B$27.59B$29.68B$34.51B$40.79B$43.98B$46.73B$49.58B$53.41B
Total liabilities and equity—$21.09B$21.63B$21.35B$26.83B$27.44B$31.86B$42.85B$40.83B$45.91B$56.67B$56.23B$58.38B$69.05B$95.12B$97.15B$98.73B$97.32B$110.3B
Total debt—$2.02B$2.18B$2.14B$7.03B$7.12B$10.49B$14.56B$12.47B$16.63B$21.01B$18.99B$18.49B$22.55B$36.34B$36.07B$36.42B$32.78B$40.85B
Net debt—$730.0M$610.3M$1.21B$6.01B$6.31B$4.66B$13.21B$12.02B$15.84B$19.67B$16.89B$16.09B$12.22B$31.86B$27.55B$28.34B$27.21B$30.75B
Net working capital—$1.53B$1.33B$1.51B$692.5M$1.94B$928.7M−$153.5M$1.14B$1.37B$1.04B$2.38B$3.30B$1.33B$2.20B−$305.0M$2.50B$4.80B$3.67B
Shares outstanding · period end——409M391M366M358M392M397M396M390M402M399M399M394M391M385M381M377M371M

Quarterly

Thermo Fisher Scientific balance sheet, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Cash and equivalents$8.08B$5.50B$7.07B$4.64B$4.01B$4.13B$4.58B$1.98B$9.85B$3.25B$4.06B$5.46B
Short-term investments$3.00M$1.75B$1.75B$2.00B$1.56B$1.81B$1.81B$1.56B$253.0M$2.00M$0.00$600.0M
Cash and short-term investments$8.08B$7.25B$8.82B$6.64B$5.57B$5.95B$6.39B$3.55B$10.11B$3.26B$4.06B$6.06B
Accounts receivable$8.22B$7.93B$7.94B$8.26B$8.19B$8.46B$8.59B$8.91B$8.90B$9.20B$9.45B$9.63B
Inventory$5.09B$5.13B$5.20B$5.43B$4.98B$5.22B$5.56B$5.75B$5.42B$5.50B$5.63B$5.64B
Current assets$24.59B$23.64B$25.48B$23.78B$22.14B$23.38B$24.58B$22.30B$28.71B$22.32B$23.36B$25.61B
Property, plant and equipment$9.45B$9.32B$9.28B$9.41B$9.31B$9.33B$9.63B$10.18B$10.56B$10.66B$10.76B$10.58B
Goodwill$44.02B$43.84B$43.84B$46.73B$45.85B$46.49B$47.25B$49.29B$49.36B$55.19B$54.83B$54.26B
Acquired intangibles$16.67B$16.05B$15.52B$16.26B$15.53B$15.32B$15.15B$16.24B$15.84B$19.15B$18.61B$18.08B
Total assets$98.73B$97.09B$98.50B$100.4B$97.32B$99.04B$101.2B$103.0B$110.3B$113.3B$113.2B$114.2B
Accounts payable$2.87B$2.56B$2.55B$2.61B$3.08B$3.05B$2.98B$3.12B$3.62B$3.34B$3.27B$3.09B
Unearned revenue, current$2.69B$2.63B$2.59B$2.66B$2.85B$2.87B$2.81B$2.85B$2.71B$2.93B$2.92B$2.94B
Long-term debt · current portion$3.61B$4.45B$5.12B$4.12B$2.21B$2.82B$2.21B$3.82B$3.53B$3.09B$3.37B$2.26B
Current liabilities$14.01B$13.94B$14.77B$14.60B$13.33B$13.17B$12.72B$14.89B$15.19B$14.62B$15.07B$14.17B
Long-term debt · non-current$31.31B$31.16B$30.28B$31.20B$29.06B$31.37B$33.02B$31.86B$35.85B$40.07B$39.18B$39.11B
Operating lease liability$1.51B———$1.50B———$1.47B———
Finance lease liability$190.0M$215.0M$207.0M$200.0M$202.0M$200.0M$196.0M$196.0M$213.0M$213.0M$264.0M$262.0M
Total liabilities$51.88B$51.47B$50.96B$51.27B$47.65B$49.56B$50.63B$51.87B$56.81B$61.22B$60.37B$59.34B
Retained earnings$47.36B$48.54B$49.94B$51.42B$53.10B$54.45B$55.90B$57.35B$59.16B$60.63B$62.19B$63.74B
Minority interest−$11.00M−$12.00M−$12.00M−$20.00M−$33.00M−$33.00M−$35.00M$7.00M$7.00M$7.00M$7.00M$6.00M
Shareholders' equity$46.73B$45.52B$47.43B$48.99B$49.58B$49.39B$50.51B$51.02B$53.41B$51.93B$52.68B$54.76B
Total liabilities and equity$98.73B$97.09B$98.50B$100.4B$97.32B$99.04B$101.2B$103.0B$110.3B$113.3B$113.2B$114.2B
Total debt$36.42B$35.61B$35.41B$35.31B$32.78B$34.19B$35.23B$35.68B$40.85B$43.16B$42.55B$41.37B
Net debt$28.34B$28.36B$26.58B$28.67B$27.21B$28.24B$28.84B$32.13B$30.75B$39.91B$38.48B$35.31B
Net working capital$2.50B$4.20B$3.63B$4.54B$4.80B$6.07B$7.29B$5.42B$3.67B$4.44B$4.23B$5.98B
Shares outstanding · period end381M382M382M383M377M377M378M376M371M372M370M371M

The main figures as JSON and plain text. See data and methodology.

TMO in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.